As HER2 is a well-known crucial oncogene in BC, which activates multiple signaling pathways, including the mitogen-activated protein kinase (MAPK), PI3K/Akt, and STAT pathways, MNX1 may serve as one of the target genes in these pathways. This evidence concerns the gene MNX1 and breast cancer.